243 related articles for article (PubMed ID: 33675149)
21. Size-based isolation of circulating tumor cells in lung cancer patients using a microcavity array system.
Hosokawa M; Kenmotsu H; Koh Y; Yoshino T; Yoshikawa T; Naito T; Takahashi T; Murakami H; Nakamura Y; Tsuya A; Shukuya T; Ono A; Akamatsu H; Watanabe R; Ono S; Mori K; Kanbara H; Yamaguchi K; Tanaka T; Matsunaga T; Yamamoto N
PLoS One; 2013; 8(6):e67466. PubMed ID: 23840710
[TBL] [Abstract][Full Text] [Related]
22. [The detection of circulating hepatocellular carcinoma cells in peripheral venous blood by reverse transcription-polymerase chain reaction and its clinical significance].
Liu Y; Zhang B; Qian G; Chen H; Wu M; Fu J; Huang C
Zhonghua Wai Ke Za Zhi; 1998 Oct; 36(10):608-10. PubMed ID: 11825477
[TBL] [Abstract][Full Text] [Related]
23. High-Specific Isolation and Instant Observation of Circulating Tumour Cell from HCC Patients via Glypican-3 Immunomagnetic Fluorescent Nanodevice.
Chu Q; Mu W; Lan C; Liu Y; Gao T; Guan L; Fang Y; Zhang Z; Liu Y; Liu Y; Zhang N
Int J Nanomedicine; 2021; 16():4161-4173. PubMed ID: 34168446
[TBL] [Abstract][Full Text] [Related]
24. IGFBP1 in epithelial circulating tumor cells as a potential response marker to selective internal radiation therapy in hepatocellular carcinoma.
Nel I; Baba HA; Weber F; Sitek B; Eisenacher M; Meyer HE; Schlaak JF; Hoffmann AC
Biomark Med; 2014; 8(5):687-98. PubMed ID: 25123037
[TBL] [Abstract][Full Text] [Related]
25. Quantified postsurgical small cell size CTCs and EpCAM
Wang L; Li Y; Xu J; Zhang A; Wang X; Tang R; Zhang X; Yin H; Liu M; Wang DD; Lin PP; Shen L; Dong J
Cancer Lett; 2018 Jan; 412():99-107. PubMed ID: 29031565
[TBL] [Abstract][Full Text] [Related]
26. Circulating tumor cells as a prognostic biomarker in patients with hepatocellular carcinoma.
Prasoppokakorn T; Buntho A; Ingrungruanglert P; Tiyarattanachai T; Jaihan T; Kulkraisri K; Ariyaskul D; Phathong C; Israsena N; Rerknimitr R; Treeprasertsuk S; Chaiteerakij R
Sci Rep; 2022 Nov; 12(1):18686. PubMed ID: 36333384
[TBL] [Abstract][Full Text] [Related]
27. Quantitative comparison of alpha-fetoprotein and albumin mRNA levels in hepatocellular carcinoma/adenoma, non-tumor liver and blood: implications in cancer detection and monitoring.
Wong IH; Lau WY; Leung T; Johnson PJ
Cancer Lett; 2000 Aug; 156(2):141-9. PubMed ID: 10880763
[TBL] [Abstract][Full Text] [Related]
28. Mycoplasma infection promotes tumor progression via interaction of the mycoplasmal protein p37 and epithelial cell adhesion molecule in hepatocellular carcinoma.
Kim MK; Shin SJ; Lee HM; Choi HS; Jeong J; Kim H; Paik SS; Kim M; Choi D; Ryu CJ
Cancer Lett; 2019 Jul; 454():44-52. PubMed ID: 30980864
[TBL] [Abstract][Full Text] [Related]
29. Semiquantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction.
Wong IH; Leung T; Ho S; Lau WY; Chan M; Johnson PJ
Br J Cancer; 1997; 76(5):628-33. PubMed ID: 9303362
[TBL] [Abstract][Full Text] [Related]
30. Detecting carcinoma cells in peripheral blood of patients with hepatocellular carcinoma by immunomagnetic beads and rt-PCR.
Guo J; Yao F; Lou Y; Xu C; Xiao B; Zhou W; Chen J; Hu Y; Liu Z
J Clin Gastroenterol; 2007 Sep; 41(8):783-8. PubMed ID: 17700428
[TBL] [Abstract][Full Text] [Related]
31. The mesenchymal circulating tumor cells as biomarker for prognosis prediction and supervision in hepatocellular carcinoma.
Zhao L; Zheng Z; Liu Y; Liu F; Li X; Wu Z
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6035-6048. PubMed ID: 36633681
[TBL] [Abstract][Full Text] [Related]
32. Prospective evaluation of circulating hepatocytes by alpha-fetoprotein messenger RNA in patients with hepatocellular carcinoma.
Witzigmann H; Geissler F; Benedix F; Thiery J; Uhlmann D; Tannapfel A; Wittekind C; Hauss J
Surgery; 2002 Jan; 131(1):34-43. PubMed ID: 11812961
[TBL] [Abstract][Full Text] [Related]
33. Circulating Tumor Cell Phenotype Indicates Poor Survival and Recurrence After Surgery for Hepatocellular Carcinoma.
Ou H; Huang Y; Xiang L; Chen Z; Fang Y; Lin Y; Cui Z; Yu S; Li X; Yang D
Dig Dis Sci; 2018 Sep; 63(9):2373-2380. PubMed ID: 29926241
[TBL] [Abstract][Full Text] [Related]
34. Clinical Impact of Circulated miR-1291 in Plasma of Patients with Liver Cirrhosis (LC) and Hepatocellular Carcinoma (HCC): Implication on Glypican-3 Expression.
Hagag NA; Ali YBM; Elsharawy AA; Talaat RM
J Gastrointest Cancer; 2020 Mar; 51(1):234-241. PubMed ID: 31028536
[TBL] [Abstract][Full Text] [Related]
35. A clinically feasible circulating tumor cell sorting system for monitoring the progression of advanced hepatocellular carcinoma.
Huang XY; Li F; Li TT; Zhang JT; Shi XJ; Huang XY; Zhou J; Tang ZY; Huang ZL
J Nanobiotechnology; 2023 Jan; 21(1):25. PubMed ID: 36681851
[TBL] [Abstract][Full Text] [Related]
36. Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinoma.
Yao M; Yao DF; Bian YZ; Wu W; Yan XD; Yu DD; Qiu LW; Yang JL; Zhang HJ; Sai WL; Chen J
Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):171-9. PubMed ID: 23558072
[TBL] [Abstract][Full Text] [Related]
37. Circulating Hepatocellular Cells are a Bad Prognostic Factor for HCC Patients.
Liu Y; Wang YR; Wang L; Xun LJ; Ding GH; Yao L
Hepatogastroenterology; 2015 Jun; 62(140):802-6. PubMed ID: 26902005
[TBL] [Abstract][Full Text] [Related]
38. Can Glypican3 be diagnostic for early hepatocellular carcinoma among Egyptian patients?
Abdelgawad IA; Mossallam GI; Radwan NH; Elzawahry HM; Elhifnawy NM
Asian Pac J Cancer Prev; 2013; 14(12):7345-9. PubMed ID: 24460300
[TBL] [Abstract][Full Text] [Related]
39. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells].
Li BD; Zhao QC; Zhu YT; Zhang FQ; Dou KF
Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):458-62. PubMed ID: 16772080
[TBL] [Abstract][Full Text] [Related]
40. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood.
Komeda T; Fukuda Y; Sando T; Kita R; Furukawa M; Nishida N; Amenomori M; Nakao K
Cancer; 1995 May; 75(9):2214-9. PubMed ID: 7536120
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
